Moreover, T-cell activation, as exemplified by upregulation of activation markers (Figure 2E) and downstream TCR signaling (i.e., AKT pathway) (Figure 2F), was significantly attenuated by CLL-EVs. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.